Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002921-39Phase 2Completed
Phase 2, randomised trial in None comparing Hyperbaric bupivacaine with Hyperbaric prilocaine (2 arms). Primary endpoint: Motor block duration (Bromage score 0). Started Jan 2018; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002921-39.